Masters JR - Search Results

1

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer.

Brown RS, Dogan A, Ell PJ, Payne HA, Masters JR, Harland SJ. Brown RS, et al. Among authors: masters jr. Prostate Cancer Prostatic Dis. 2002;5(2):144-51. doi: 10.1038/sj.pcan.4500581. Prostate Cancer Prostatic Dis. 2002. PMID: 12497005 Clinical Trial.

2

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.

Brown RS, Edwards J, Dogan A, Payne H, Harland SJ, Bartlett JM, Masters JR. Brown RS, et al. Among authors: masters jr. J Pathol. 2002 Oct;198(2):237-44. doi: 10.1002/path.1206. J Pathol. 2002. PMID: 12237884

3

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.

Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Birtle AJ, et al. Among authors: masters jr. Cancer. 2003 Dec 1;98(11):2362-7. doi: 10.1002/cncr.11821. Cancer. 2003. PMID: 14635070 Free article.

4

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL.

Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Birtle AJ, et al. Among authors: masters jr. BJU Int. 2005 Aug;96(3):303-7. doi: 10.1111/j.1464-410X.2005.05619.x. BJU Int. 2005. PMID: 16042718

5

ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.

Masters JR, McDermott BJ, Harland S, Bibby MC, Loadman PM. Masters JR, et al. Cancer Chemother Pharmacol. 1996;38(1):59-64. doi: 10.1007/s002800050448. Cancer Chemother Pharmacol. 1996. PMID: 8603453 Clinical Trial.

6

Plexin-B1 mutations in prostate cancer.

Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, Constantinou J, Feneley MR, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR, Williamson M. Wong OG, et al. Among authors: masters jr. Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19040-5. doi: 10.1073/pnas.0702544104. Epub 2007 Nov 16. Proc Natl Acad Sci U S A. 2007. PMID: 18024597 Free PMC article.

7

Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

Birtle AJ, Freeman A, Payne HA, Masters JR, Harland SJ. Birtle AJ, et al. Among authors: masters jr. BJU Int. 2003 Sep;92(4):490. doi: 10.1046/j.1464-410x.2003.t01-1-04376.x. BJU Int. 2003. PMID: 12930449 No abstract available.

8

Prostate cancer stem cell therapy: hype or hope?

Masters JR, Kane C, Yamamoto H, Ahmed A. Masters JR, et al. Prostate Cancer Prostatic Dis. 2008;11(4):316-9. doi: 10.1038/pcan.2008.22. Epub 2008 Apr 22. Prostate Cancer Prostatic Dis. 2008. PMID: 18427568 Review.

9

Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH.

Brookman-Amissah N, Duchesnes C, Williamson MP, Wang Q, Ahmed A, Feneley MR, Mackay A, Freeman A, Fenwick K, Iravani M, Weber B, Ashworth A, Masters JR. Brookman-Amissah N, et al. Among authors: masters jr. Prostate Cancer Prostatic Dis. 2005;8(4):335-43. doi: 10.1038/sj.pcan.4500826. Prostate Cancer Prostatic Dis. 2005. PMID: 16130014

10

A role for class 3 semaphorins in prostate cancer.

Blanc V, Nariculam J, Munson P, Freeman A, Klocker H, Masters J, Williamson M. Blanc V, et al. Prostate. 2011 May;71(6):649-58. doi: 10.1002/pros.21281. Epub 2010 Oct 14. Prostate. 2011. PMID: 20949546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters